GOBLET CELL CARCINOID/ADENOCARCINOMA

Clinical trials for GOBLET CELL CARCINOID/ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new GOBLET CELL CARCINOID/ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for GOBLET CELL CARCINOID/ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New mRNA vaccine aims to stop colorectal cancer recurrence in High-Risk patients

Disease control Ongoing

This study tests an experimental mRNA vaccine (RO7198457) in people with stage 2 or 3 colorectal cancer who had surgery but still have cancer DNA in their blood. The goal is to see if the vaccine can prevent the cancer from returning better than simply watching and waiting. About…

Matched conditions: GOBLET CELL CARCINOID/ADENOCARCINOMA

Phase: PHASE2 • Sponsor: BioNTech SE • Aim: Disease control

Last updated Jun 16, 2026 12:54 UTC

GOBLET CELL CARCINOID/ADENOCARCINOMA

Get alerted when new GOBLET CELL CARCINOID/ADENOCARCINOMA trials appear

New mRNA vaccine aims to stop colorectal cancer recurrence in High-Risk patients